CN1153578C - Medicine for treating bone fracture and osteopathy - Google Patents

Medicine for treating bone fracture and osteopathy Download PDF

Info

Publication number
CN1153578C
CN1153578C CNB991221737A CN99122173A CN1153578C CN 1153578 C CN1153578 C CN 1153578C CN B991221737 A CNB991221737 A CN B991221737A CN 99122173 A CN99122173 A CN 99122173A CN 1153578 C CN1153578 C CN 1153578C
Authority
CN
China
Prior art keywords
medicine
present
fractures
bone
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB991221737A
Other languages
Chinese (zh)
Other versions
CN1294007A (en
Inventor
魏玉玲
李懿高
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yunnan Crystal Natural Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB991221737A priority Critical patent/CN1153578C/en
Publication of CN1294007A publication Critical patent/CN1294007A/en
Application granted granted Critical
Publication of CN1153578C publication Critical patent/CN1153578C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to an oral preparation extracted from natural plants, which has therapeutic action for fractures and bone diseases. The medicine of the present invention for treating fractures and bone diseases is prepared from the raw materials of the following dosage: 15 to 45g of safflower, 6 to 12g of flos daturae, 10 to 30g of tangerine peel, 30 to 90g of sanchi, 40 to 90g of membranous milkvetch root, 20 to 60g of ginseng, 30 to 60g of eucommia bark, 10 to 20g of turtle shell and 10 to 18g of Chinese hydrangeavine root-bark. The medicine has no toxic side effect, and has obvious effect of pain alleviation, swelling elimination and fracture union promotion through acute toxicity tests and the certification of long-term toxicity tests. The present invention is called bone king. Besides, the effective rate of the present invention for treating various fresh fractures and old fractures can reach 96.6%.

Description

The medicine of treatment bone fracture and osteopathy
The present invention relates to a kind of by extract in the natural plants to the fracture, the medicative oral formulations of osteopathia.
Chinese patent application CN98101887.4 discloses " a kind of medicine for the treatment of fracture ", is formed by Radix Angelicae Sinensis, Rhizoma Chuanxiong, the Radix Paeoniae Alba, Radix Rehmanniae Preparata, the Cortex Eucommiae, Radix Dipsaci, Radix Notoginseng, Cortex Acanthopancis, Rhizoma Drynariae, Ramulus Cinnamomi, the Radix Astragali, Os Tigris, POGUZHI, ripe cake, DANGSHEN, Fructus Chaenomelis, Herba Artemisiae Anomalae and Eupolyphaga Seu Steleophaga 18 flavor Chinese medicines.It act as benefiting qi and nourishing blood, hemopoietic collateral dredging, repercussive pain relieving, promotes the fracture organization of hematoma, and primary callus is formed as early as possible, shortens the time that it becomes permanent callus.Chinese patent application CN95109064.X discloses a kind of " quick-action bone injury medicine and preparation method ", formulated by Pyritum, Moschus, Radix Zanthoxyli, Radix Belladonnae, Carapax Trionycis, Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae), the Cortex Eucommiae, Radix Ginseng, Radix Notoginseng, Radix Angelicae Sinensis, Rhizoma Dioscoreae, Caulis Entadae, Colla cornus cervi, the Radix Astragali, Flos Carthami, Radix seu Caulis Embeliae Parviflorae, be mainly used in the treatment of fracture and bone injury.
Purpose of the present invention aims to provide a kind of pure natural medical for the treatment of fracture, osteopathia.
The Department of Pharmacy of treatment bone fracture and osteopathy of the present invention is made by the raw material of following consumption: Flos Carthami 15--45g, Flos Daturae 6--12g, Pericarpium Citri Reticulatae 10--30g, Radix Notoginseng 30--90g, Radix Astragali 40--90g, Radix Ginseng 20--60g, Cortex Eucommiae 30--60g, Carapax Trionycis 10--20g, Cortex schizophragmatis integrifolii radicis 10--18g.
Medicine of the present invention is through acute toxicity test, long term toxicity test proves, have no side effect, through the various big hospital clinical verification, this medicine has the effect of tangible pain relieving, detumescence, promotion union of fracture, and treatment all kinds fresh fracture and old fracture effective percentage are reached 96.6%, diseases such as treatment osteopathia (fracture delayed union, bone does not connect, femur head necrosis, osteomyelitis, cervical spondylosis, hyperosteogeny, prolapse of lumbar intervertebral disc and osteoporosis etc.), scapulohumeral periarthritis, soft tissue injury, bursitis, rheumatic numbness are had significant curative effect.This Department of Pharmacy selects distinctive rare medical material for use, through the refining pure natural medical that forms of modern scientific method, be commonly called as " bone king ", the reparation that this medicine has condensed modern pharmacology theory and Chinese medicine " bone of kidney ", " stasis of blood bone new life " and fracture at first relies on the classical theories such as growth of blood, thereby make this medicine forceful drug effect, drug effect continue, and play strengthening the body resistance, constitutional effect.Shortened healing time greatly, made bone fracture bone fracture disease rare, for the insoluble difficult bone injury of present dependence modern medicine, osteopathia pertinacious disease, have special therapeutic effect, this medicine will have more wide prospect in therapeutic domain.
Embodiment:
Get Flos Carthami 15g, Flos Daturae 6g, Pericarpium Citri Reticulatae 10g, Radix Notoginseng 30g, Radix Astragali 40g, Cortex schizophragmatis integrifolii radicis 10g, Radix Ginseng 20g, Cortex Eucommiae 30g, Carapax Trionycis 10g, through roughly select, selected after, weigh, wash with water, soak, extract respectively, filter, dosing, make mixture, fill is sealed, sterilization, detect, packing gets product.

Claims (1)

  1. A kind of medicine for the treatment of bone fracture and osteopathy is characterized in that being made by the raw material of following consumption: Flos Carthami 15--45g, Flos Daturae 6--12g, Pericarpium Citri Reticulatae 10--30g, Radix Notoginseng 30--90g, Radix Astragali 40--90g, Radix Ginseng 20--60g, Cortex Eucommiae 30--60g, Carapax Trionycis 10--20g, Cortex schizophragmatis integrifolii radicis 10--18g.
CNB991221737A 1999-11-01 1999-11-01 Medicine for treating bone fracture and osteopathy Expired - Lifetime CN1153578C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB991221737A CN1153578C (en) 1999-11-01 1999-11-01 Medicine for treating bone fracture and osteopathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB991221737A CN1153578C (en) 1999-11-01 1999-11-01 Medicine for treating bone fracture and osteopathy

Publications (2)

Publication Number Publication Date
CN1294007A CN1294007A (en) 2001-05-09
CN1153578C true CN1153578C (en) 2004-06-16

Family

ID=5282334

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB991221737A Expired - Lifetime CN1153578C (en) 1999-11-01 1999-11-01 Medicine for treating bone fracture and osteopathy

Country Status (1)

Country Link
CN (1) CN1153578C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105709011A (en) * 2015-04-17 2016-06-29 孙月中 Capsule for treating lumbar disc hernation
CN108283675A (en) * 2018-03-29 2018-07-17 云南克雷斯制药股份有限公司 A kind of Chinese medicine composition and its purposes in preparing treatment caput femoris necrosis drug

Also Published As

Publication number Publication date
CN1294007A (en) 2001-05-09

Similar Documents

Publication Publication Date Title
CN101485836A (en) Oral capsule for treating neck, waist and leg pain diseases and preparation method thereof
CN102512630B (en) Traditional Chinese medicine composition for treating gallbladder calculus
CN101249220A (en) Oral capsule for curing cervicobrachia, lumbodynia and leg pain and method of preparing the same
CN104857157A (en) Decoction medicine for treating endometrial hyperplasia and preparation method thereof
CN103349753B (en) Traditional Chinese medicine composition for treating kidney deficiency
CN102988672B (en) Traditional Chinese medicine composition for treating irregular menstruation
CN103705797A (en) Drug for treating kidney stones
CN102357227A (en) Chinese medicinal composition for treating qi stagnation and blood stasis amenorrhea
CN102416146B (en) Chinese medicinal composition for treating amenorrhea
CN1153578C (en) Medicine for treating bone fracture and osteopathy
CN1064245C (en) Medicine for hyperosteogeny
CN101732661A (en) Chinese medicament for treating fracture
CN104524080A (en) Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method
CN104547489A (en) Use of traditional Chinese medicine composition in preparation of medicine for treating comminuted fracture
CN103520662A (en) Traditional Chinese medicine formula for treating ankylosing spondylitis
CN1175875C (en) Medicine made of lysimachia for treating hepatobiliary calculus and its prescription
CN1071576C (en) External application medicinal bag for curing cancerbus ache and incision ache after operation and its preparing method
CN108888736B (en) External-use bone reunion medicine and preparation method thereof
CN102100797A (en) Chinese herba preparation for treating spinal tuberculosis
CN105816603A (en) Traditional Chinese medicine composition for treating postpartum hemorrhage
CN104587394A (en) Traditional Chinese medicine composition for treating delayed union and nonunion
CN105535510A (en) Traditional Chinese medicine composition for treating sciatica
CN104800703A (en) Traditional Chinese medicine composition for treating irregular menstruation
CN105343862A (en) Drug composition for soft tissue injury and fracture
CN104771605A (en) Traditional Chinese medicine composition for treating low back and leg pain

Legal Events

Date Code Title Description
BB1A Publication of application
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Assignee: Yunnan crystal Natural Pharmaceutical Co. Ltd.

Assignor: Wei Yuling

Contract record no.: 2011530000057

Denomination of invention: Medicine for treating bone fracture and osteopathy

Granted publication date: 20040616

License type: Exclusive License

Open date: 20010509

Record date: 20110805

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20151218

Address after: 650041, Jintai building, No. 48 Dongfeng Dong Road, Yunnan, Kunming, 906

Patentee after: Yunnan crystal Natural Pharmaceutical Co. Ltd.

Address before: 306, room 2, building 10, 650051 Renmin East Road, Kunming, Yunnan

Patentee before: Wei Yuling

C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: 650041, Jintai building, No. 48 Dongfeng Dong Road, Yunnan, Kunming, 906

Patentee after: YUNNAN CRYSTAL NATURAL PHARMACEUTICAL CO., LTD.

Address before: 650041, Jintai building, No. 48 Dongfeng Dong Road, Yunnan, Kunming, 906

Patentee before: Yunnan crystal Natural Pharmaceutical Co. Ltd.

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20040616